MREO

NASDAQ · Equity

Mereo BioPharma Group PLC ADR

US Healthcare Biotechnology

Latest week
29 May 2026
Close
0.344000
Fair value
2.357359
Expectation
Negative 42.72%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
0.34
12-Week Change
-10.88%
Trend Signal
Inactive
Expectation
Negative 42.72%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-79.42
Market Dynamics
0.40

Over the latest 12 completed weeks ending 2026-05-29, MREO fell 10.88%, moving from 0.39 to 0.34. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -79.42 and has improved across the 12-week window. Market Dynamics is 0.40 on the latest week. Expectation is negative at 42.72%.